SCHOTT Builds Second Melting Tank for Pharmaceutical Glass Tubing in Mainz
The international specialty glass manufacturer SCHOTT is building a
second melting tank for pharmaceutical glass tubing at its main plant in
Mainz, Germany. The investment volume amounts to 40 million euros. The
new production facility is scheduled to go into operation in mid-2022
and will then offer 100 new jobs, 50 of which will be directly at
SCHOTT. With this investment, SCHOTT is responding to the dynamically
increasing global demand for glass tubing for pharmaceutical packaging. More info >>
galenIQ combines a multitude of outstanding characteristics and is suitable for a wide range of pharmaceutical applications. galenIQ can be used as more than just a bulk excipient. It also serves as an anti-caking agent, anti-humectant agent, stabilizer or oral care and taste agent to mention just a few additional functions. More info >>
DIA Europe is the must-attend event for all life science professionals
working in drug development, from discovery to marketed use. It
encourages open collaboration by bringing together representatives from
the entire spectrum of the life science landscape and facilitating
crucial discussions across several topic tracks: Clinical Development,
Regulatory Strategy, Pharmacovigilance, Value and Access, Health Policy,
and many more. More info >>
